What is the association between the microbiome and cognition? An umbrella review protocol.

Publication date: Jun 18, 2024

Cognitive impairment is reported in a variety of clinical conditions including Alzheimer’s disease, Parkinson’s and ‘long-COVID’. Interestingly, many of these clinical conditions are also associated with microbial dysbiosis. This comanifestation of cognitive and microbiome findings in seemingly unrelated maladies suggests that they could share a common mechanism and potentially presents a treatment target. Although a rapidly growing body of literature has documented this comorbid presentation within specific conditions, an overview highlighting potential parallels across healthy and clinical populations is lacking. The objective of this umbrella review, therefore, is to summarise and synthesise the findings of these systematic reviews. On 2 April 2023, we searched MEDLINE (Pubmed), Embase (Ovid), the Web of Science (Core Collection), the Cochrane Library of Systematic Reviews and Epistemonikos as well as grey literature sources, for systematic reviews on clinical conditions and interventions where cognitive and microbiome outcomes were coreported. An updated search will be conducted before completion of the project if the search-to-publication date is >1 year old. Screening, data abstraction and quality assessment (AMSTAR 2, A MeaSurement Tool to Assess systematic Reviews) will be conducted independently and in duplicate, with disagreements resolved by consensus. Evidence certainty statements for each review’s conclusions (eg, Grading of Recommendations Assessment, Development and Evaluation (GRADE)) will be extracted or constructed de novo. A narrative synthesis will be conducted and delineated by the review question. Primary study overlap will be visualised using a citation matrix as well as calculated using the corrected covered area method. No participant-identifying information will be used in this review. No ethics approval was required due to our study methodology. Our findings will be presented at national and international conferences and disseminated via social media and press releases. We will recruit at least one person living with cognitive impairment to collaborate on writing the plain language summary for the review. CRD42023412903.

Open Access PDF

Concepts Keywords
Alzheimer Alzheimer Disease
Crd42023412903 Cognition
Library Cognitive Dysfunction
Medline COVID-19
Recruit Delirium & cognitive disorders
Dementia
Dysbiosis
GASTROENTEROLOGY
Humans
Microbiota
Parkinson Disease
Research Design
Systematic Review

Semantics

Type Source Name
disease MESH Cognitive impairment
disease MESH Alzheimer’s disease
disease MESH dysbiosis
disease MESH ‘long COVID
disease MESH Parkinson’s disease
disease MESH sequelae
disease MESH cancer
disease MESH inflammation
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Coenzyme M
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Profenamine
pathway REACTOME Translation
disease MESH syndrome
disease MESH irritable bowel syndrome
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH Arthritis
disease MESH systemic lupus erythematosus
pathway KEGG Systemic lupus erythematosus
disease MESH infections
disease MESH neurological disorders
disease MESH Neuroinflammation
disease MESH obesity
disease MESH Western diet
disease MESH stroke
disease MESH dementia
disease MESH multiple sclerosis
disease MESH inflammatory bowel disease
pathway KEGG Inflammatory bowel disease
disease MESH causality
pathway KEGG Alzheimer disease
disease MESH COVID-19
disease MESH Delirium
pathway KEGG Parkinson disease

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *